AIC
MRNA icon

Aurora Investment Counsel’s Moderna MRNA Stock Holding History

Aurora Investment Counsel’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,953
Closed -$512K – 120
2023
Q3 		$512K Sell
4,953
-1,986
-29% -$222K 0.34% 107
2023
Q2 		$843K Sell
6,939
-152
-2% -$20.3K 0.54% 104
2023
Q1 		$1.09M Buy
7,091
+5
+0.1% +$825 0.71% 82
2022
Q4 		$1.27M Sell
7,086
-236
-3% -$38.6K 0.88% 58
2022
Q3 		$866K Sell
7,322
-598
-8% -$90.7K 0.66% 86
2022
Q2 		$1.13M Buy
7,920
+889
+13% +$127K 0.82% 61
2022
Q1 		$1.21M Buy
7,031
+1,221
+21% +$206K 0.77% 67
2021
Q4 		$1.48M Buy
5,810
+2,842
+96% +$831K 0.88% 55
2021
Q3 		$1.14M Sell
2,968
-607
-17% -$224K 0.8% 66
2021
Q2 		$840K Buy
+3,575
New +$639K 0.59% 91

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Aurora Investment Counsel's MRNA Position: Q4 2023 in Review

Aurora Investment Counsel sold out of Moderna (MRNA) in Q4 2023, closing a stake of 4,953 shares — an estimated $512K sold.

Aurora Investment Counsel first reported a position in MRNA in Q2 2021 and held it in 10 quarters. The position peaked at $1.48M in Q4 2021. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Aurora Investment Counsel reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Aurora Investment Counsel sold 4,953 Moderna shares in Q4 2023, an estimated $512K.
  • Aurora Investment Counsel first reported a position in Moderna in Q2 2021 and held it in 10 quarters.
  • Aurora Investment Counsel's Moderna position peaked at $1.48M in Q4 2021.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Aurora Investment Counsel's 13F filing for Q4 2023, filed 20 Feb 2024.